Search clinical trials for: Lenalidomide, Decitabine
Total 4078 results
-
H. Lee Moffitt Cancer Center and Research InstituteBlueprint Medicines CorporationRecruitingSystemic Mastocytosis With an Associated Hematologic NeoplasmUnited States
-
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital of Anhui Medical University; Henan Cancer Hospital and other collaboratorsRecruitingInduction Chemotherapy | Acute T-Lymphocytic Leukemia | T-cell Lymphoblastic Lymphoma Leukemia | T-cell/Myeloid Mixed Phenotype Acute LeukemiaChina
-
The First Affiliated Hospital with Nanjing Medical...Huai'an First People's Hospital; Yancheng First People's Hospital; The Affiliated...RecruitingAcute Myeloid LeukemiaChina
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Hospital Universitario GetafeUnknown
-
Centre Hospitalier Universitaire, AmiensInstitut Bergonié; Centre Henri Becquerel; Saint-Louis Hospital, Paris, France; Henri Mondor University Hospital and other collaboratorsRecruitingChemotherapy | Elderly | Diffuse Large B-Cell Lymphoma (DLBCL), NosFrance
-
Wuerzburg University HospitalCelgene Corporation; ClinAssess GmbHActive, not recruitingPreviously Untreated Symptomatic Multiple MyelomaGermany
-
Incyte CorporationTerminatedMetastatic Cancer | Solid Tumors | Advanced MalignanciesUnited States
-
The First Affiliated Hospital of Soochow UniversityNot yet recruitingB-cell Acute Lymphoblastic LeukemiaChina
-
Second Affiliated Hospital, School of Medicine,...RecruitingObjective Response RateChina
-
Massachusetts General HospitalAstraZeneca; Astex Pharmaceuticals, Inc.Active, not recruitingHead and Neck CancerUnited States
-
Washington University School of MedicineCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States
-
Groupe Francophone des MyelodysplasiesCelgeneCompletedLenalidomide Combined to Azacitidine in Intermediate-2 or High Risk MDS With Del 5q (GFM-AZA-REV-09)Myelodysplastic SyndromesFrance
-
Nordic MDS GroupUnknownMyelodysplastic Syndrome | Acute Myelogenous LeukemiaSweden
-
University Hopsital Schleswig Holstein Campus LübeckRecruitingNewly Diagnosed Multiple MyelomaGermany
-
Sierra Oncology LLC - a GSK companyCompletedAdvanced Solid TumorsSpain, United Kingdom
-
Weill Medical College of Cornell UniversityCelgeneActive, not recruiting
-
Mikkael Sekeres MDNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Sunnybrook Health Sciences CentreCelgeneCompletedMyelodysplastic Syndromes | Leukemia, Myelomonocytic, Chronic | AngiogenesisCanada
-
Seagen Inc.TerminatedAcute Myeloid LeukemiaKorea, Republic of, United States, Spain, Belgium, Germany, Czechia, Hungary, Taiwan, France, Israel, Italy, United Kingdom, Australia, Austria, Poland, Luxembourg
-
The First Affiliated Hospital of Soochow UniversityRecruitingAcute Myeloid LeukemiaChina
-
First Affiliated Hospital of Zhejiang UniversityRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesChina
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI); Celgene CorporationCompletedMultiple MyelomaUnited States
-
The Lymphoma Academic Research OrganisationRecruitingMarginal Zone LymphomaFrance
-
Gesellschaft fur Medizinische Innovation - Hamatologie...ClinAssess GmbHCompletedMultiple MyelomaGermany
-
University of Erlangen-Nürnberg Medical SchoolCompleted
-
Chinese PLA General HospitalNot yet recruitingPD-1 Inhibitor Failed Patients With Classical Hodgkin Lymphoma
-
The First Affiliated Hospital of Soochow UniversityThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical... and other collaboratorsUnknownAcute Myeloid Leukemia | Allogeneic Hematopoietic Stem Cell Transplantation | ConditioningChina
-
Merck Sharp & Dohme LLCCompletedMyelodysplastic Syndromes | Leukemia, Myelocytic, Acute Myelodysplastic Syndromes
-
Janssen Pharmaceutical K.K.CompletedMyelodysplastic SyndromeJapan
-
Qingdao Central HospitalRecruiting
-
Ohio State University Comprehensive Cancer CenterCureTech LtdTerminatedMultiple MyelomaUnited States
-
Ohio State University Comprehensive Cancer CenterMerck Sharp & Dohme LLCCompletedMultiple Myeloma | Plasma Cell NeoplasmUnited States
-
Ohio State University Comprehensive Cancer CenterMorphoSys AGActive, not recruitingRecurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Stage III Small Lymphocytic Lymphoma | Stage IV Small Lymphocytic Lymphoma | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Contiguous Stage II Small Lymphocytic... and other conditionsUnited States
-
Lund University HospitalMundipharma Pte Ltd.; Roche Pharma AG; CelgeneCompletedMantle Cell LymphomaFinland, Denmark, Norway, Sweden
-
Clinical Hub for Interventional Research (CHOIR)The University of New South Wales; Australian National UniversityRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaAustralia
-
Astex Pharmaceuticals, Inc.TerminatedMyelodysplastic SyndromesUnited States
-
National Cancer Institute (NCI)Active, not recruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
Janssen Research & Development, LLCCompletedLeukemia, Myeloid, AcuteUnited States, Australia, France, Poland, Taiwan, Belgium, Germany, United Kingdom, Spain, Israel, Turkey, Korea, Republic of, Russian Federation, Sweden
-
Shenzhen University General HospitalNot yet recruiting
-
University of UtahAmgen; Eisai Inc.Completed
-
University Hospital, LilleActive, not recruiting
-
European Myeloma NetworkSanofi; Amgen; EMN Research ItalyActive, not recruitingMultiple MyelomaCzechia, Germany, Greece, Italy, Netherlands, Norway, Spain
-
University Health Network, TorontoCompletedMultiple Myeloma | Renal FailureCanada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Celgene CorporationCompletedRefractory/Relapsed Indolent Non-Hodgkin LymphomaUnited States
-
3D Medicines (Sichuan) Co., Ltd.Not yet recruitingBiliary Tract Neoplasms
-
TJ Biopharma Co., Ltd.Active, not recruitingRefractory Multiple Myeloma | Multiple Myeloma in RelapseChina, Taiwan
-
Kansai Hepatobiliary Oncology GroupCompleted
-
Sellas Life Sciences GroupUnknownMultiple Myeloma | Minimal Residual Disease | High-Risk CancerUnited States